8.4049
1.52%
0.1751
Precedente Chiudi:
$8.58
Aprire:
$8.31
Volume 24 ore:
5,611
Relative Volume:
0.60
Capitalizzazione di mercato:
$27.51M
Reddito:
-
Utile/perdita netta:
$-34.90M
Rapporto P/E:
-7.0041
EPS:
-1.2
Flusso di cassa netto:
$-33.80M
1 W Prestazione:
+2.47%
1M Prestazione:
+15.29%
6M Prestazione:
-31.90%
1 anno Prestazione:
+1,779%
Surrozen Inc Stock (SRZN) Company Profile
Nome
Surrozen Inc
Settore
Industria
Telefono
650-475-2820
Indirizzo
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-10-11 | Iniziato | BofA Securities | Buy |
2021-09-15 | Iniziato | Guggenheim | Buy |
2021-09-07 | Iniziato | Stifel | Buy |
Surrozen Inc Borsa (SRZN) Ultime notizie
Surrozen (NASDAQ:SRZN) Shares Up 2.4% - Defense World
(SRZN) Investment Analysis - Stock Traders Daily
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.60% - MSN
How to Take Advantage of moves in (SRZN) - Stock Traders Daily
Head to Head Comparison: 4D Molecular Therapeutics (NASDAQ:FDMT) vs. Surrozen (NASDAQ:SRZN) - Defense World
Here's Why We're A Bit Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Situation - Simply Wall St
SRZN Stock Earnings: Surrozen Misses EPS for Q2 2024 - InvestorPlace
Surrozen Provides Second Quarter 2024 Financial Results and Business Update - GlobeNewswire
Surrozen Provides Second Quarter 2024 Financial Results and Business Update - Yahoo Finance
Surrozen (NASDAQ:SRZN) and AIM ImmunoTech (NYSE:AIM) Head-To-Head Comparison - Defense World
Surrozen (NASDAQ:SRZN) Stock Price Up 1.3% - Defense World
(SRZN) Trading Report - Stock Traders Daily
Trading (SRZN) With Integrated Risk Controls - Stock Traders Daily
Surrozen (NASDAQ:SRZN) Stock Price Down 10.4% - Defense World
Surrozen announces director resignation - Investing.com India
Surrozen announces director resignation - Investing.com
Surrozen Announces Tim Kutzkey’s Board Resignation - TipRanks
(SRZN) Pivots Trading Plans and Risk Controls - Stock Traders Daily
SRZNSurrozen, Inc. Latest Stock News & Market Updates - StockTitan
How the (SRZN) price action is used to our Advantage - Stock Traders Daily
Board of Trustees of The Leland Stanford Junior University Has $490000 Stock Holdings in Surrozen, Inc. (NASDAQ ... - Defense World
Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique - EIN News
Surrozen Publishes Study in 'eLife' Demonstrating the - GlobeNewswire
Surrozen Publishes Study in 'eLife' Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique ... - StockTitan
Surrozen Publishes Study in 'eLife' Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique ... - Yahoo Finance
Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling - GlobeNewswire
Surrozen reports positive Phase 1a trial results for liver therapy - Investing.com India
Surrozen reports positive Phase 1a trial results for liver therapy By Investing.com - Investing.com Australia
Surrozen reports positive Phase 1a trial results for liver therapy By Investing.com - Investing.com
Surrozen reports positive Phase 1a trial results for liver therapy By Investing.com - Investing.com UK
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a ... - Investing News Network
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a ... - GlobeNewswire
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and ... - The Bakersfield Californian
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a ... - StockTitan
Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver in Milan - Investing News Network
(SRZN) On The My Stocks Page - Stock Traders Daily
Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis - GlobeNewswire
Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis - Yahoo Finance
New Strong Buy Stocks for April 12th - Yahoo Movies UK
New Strong Buy Stocks for April 12th - Yahoo Movies Canada
Surrozen (NASDAQ:SRZN) Trading Down 5.9% - Defense World
Surrozen (SRZN) Price Target Decreased by 40.00% to 20.66 - MSN
When the Price of (SRZN) Talks, People Listen - Stock Traders Daily
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial ... - GlobeNewswire
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting - GlobeNewswire Inc.
Surrozen presents data demonstrating potentialfor Wnt mimetic technologiesTipRanks.com - TipRanks
Surrozen Provides First Quarter 2024 Financial Results and Business Update - GlobeNewswire
Surrozen Provides First Quarter 2024 Financial Results and Business Update - Yahoo Finance
Surrozen CFO and COO acquires $232966 in stock warrants - Investing.com Nigeria
Surrozen director Tim Kutzkey acquires $3m in company stock By Investing.com - Investing.com Nigeria
Surrozen CFO and COO acquires $232,966 in stock warrants By Investing.com - Investing.com Nigeria
Surrozen Inc Azioni (SRZN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Surrozen Inc Azioni (SRZN) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
COLUMN GROUP III GP, LP | 10% Owner |
Apr 04 '24 |
Buy |
15.50 |
193,548 |
2,999,994 |
332,885 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):